SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-061248
Filing Date
2023-11-08
Accepted
2023-11-08 17:03:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2024_defa14a_notice__acc.htm DEFA14A 57633
2 GRAPHIC img30137965_0.jpg GRAPHIC 1918
3 GRAPHIC img30137965_1.jpg GRAPHIC 2021
4 GRAPHIC img30137965_2.jpg GRAPHIC 1852
  Complete submission text file 0000950170-23-061248.txt   67134
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-41827 | Film No.: 231389093
SIC: 2834 Pharmaceutical Preparations